According to Stratistics MRC, the Global Vitamin D Testing Market is expected to grow at a CAGR of 6.2% during the forecast period. Rising aging population and growing number of vitamin D deficiency diseases are some of the key factors favouring the market growth. However, growing price burden on patients is hampering the market. North America commanded the largest market share due to the higher healthcare expenditure as compared to other developing countries. Asia Pacific is anticipated to grow at the fastest CAGR due to increasing funds by several market vendors in the region.

Some of the key players in Vitamin D Testing market include F. Hoffmann-La Roche Ltd., Abbott Diagnostics, Vitamin D Company, Siemens Healthcare Diagnostics, Biomeriux Diasorin, Roche Diagnostics, Diazyme Laboratories, Danaher Corporation, Quest Diagnostics, Tosoh Bioscience, DiaSorin S.p.A., Qualigen and Biokit.

End Users Covered:
• Physicians’ office
• Hospitals
• ASCs

Products Covered:
• 1,25-Dihydroxy vitamin D
• 25-Hydroxy Vitamin D

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of APAC
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements